Locally manufactured PluumoPlus insulated packaging will serve US pharmaceutical, biotech and life sciences customers from Q1 2027, as a circular alternative to plastic foam.

Demand for temperature-controlled healthcare logistics in the U.S. is growing fast, with specialty medicines accounting for more than half of U.S. medicine spending, according to the IQVIA Institute.

Aeropowder, a UK-based sustainable materials company, has launched its PluumoPlus thermal packaging line to U.S. customers, with local manufacturing set to begin in Q1 2027 through a partnership with ColdCorr Insulated Packaging, the company announced.¹ The launch includes a new 2-8°C insulated mailer designed for the U.S. specialty pharmacy market.

Aeropowder, a UK based sustainable materials company currently operating in Europe, has launched its patented PluumoPlus thermal insulation products to US customers, with local production beginning in Q1 2027. The launch includes deep frozen and refrigerated thermal packaging solutions, as well as the new PluumoPlus 2-8°C Insulated Mailer for specialty pharmacies.

In the healthcare and pharmaceutical sectors, a variety of critical medicines and vaccines rely on being maintained at precisely regulated temperatures to remain safe and effective. Thermal packaging solutions protect such shipments from changes in temperature during transport, however traditionally they are made from synthetic materials.

PluumoPlus is the world’s first thermal packaging solution created from recycled feathers. This pioneering company, headquartered in London, UK is leading the way in sustainable packaging for cold chain logistics. With a focus on circular economy principles, PluumoPlus provides a high-performance, eco-friendly alternative to traditional insulation materials